Exploit Technologies, the strategic marketing and commercialisation arm of A*STAR, plays a proactive role to bridge good R&D to the industry. We do this through creating IP awareness and protection, as well as incubating both technologies and businesses, which we help to bring to market through licensing of A*STAR’s intellectual property and spinning off high potential companies.
In collaborating with Exploit Technologies, industry players can benefit from access to a pool of innovative technologies, the commercialisation of technology funding, commercialisation collaborations and licensing of technology offers. Companies can save significant costs on executing its own research and development and thereby lower its risks on R&D investment. By working with Exploit Technologies, the companies can benefit from licensing proof-of-concept technologies and integrate them into their products and processes.
In tandem with A*STAR’s mission to promote research and the broad dissemination of technology to industry to promote economic activity, Exploit Technologies adopts a flexible approach to licensing for successful collaboration with the industry players to maximise adoption of the technology.
Exploit Technologies has two dedicated commercialisation teams in the biomedical sciences and physical sciences and engineering fields.
Through technology incubation and business incubation, we maximise the commercial potential of A*STAR technologies, by bringing in industry partners in the early stages of development.
There is much market potential in A*STAR’s technologies. Opportunities abound and Exploit Technologies can help bring great research ideas from mind to market.
Please contact us to find out more about how Exploit Technologies can partner you in journey with successful commercialisation of A*STAR's technologies.